IU training prog. in molecular physiology and clinical mechanisms of lung disease

描述（由申请人提供）：此T-32培训申请在印第安纳州大学医学院，印第安纳州普渡大学印第安纳波利斯分校（lUPUI）的主要学院内进行。肺免疫生物学的拟议培训计划由一个多学科，高度协作的既定研究人员和高素质和敬业的导师组提供。我们在培训计划中包括了基础和临床转化的经典元素，研究，以及开发新技术。这些研究技能将使我们的学员能够加速肺部研究的进步，并缩小知识差距，这些差距阻碍了几十年来对大多数肺部疾病患者的表型表征，有效的预防性干预和疾病修饰甚至治疗药物的发展。由项目总监领导，他是一位著名的医生科学家和经验丰富的导师，他本人也是少数民族，并得到经验丰富的少数民族咨询委员会的直接支持，这项申请表明了我们致力于为代表性不足和少数民族科学家制定成功的培训计划。项目主任将从几个内部和一个外部委员会获得有关培训补助金运作的持续建议和反馈，该委员会由学术医学领导人组成。如果获得资助，该项目将为印第安纳州的肺病医生和科学家提供唯一的研究培训项目，该州是全国慢性肺病发病率最高的州之一。

DESCRIPTION (provided by applicant): This T-32 Training application is anchored within the Indiana University School of Medicine, the principal School of the Indiana University Purdue University at Indianapolis (lUPUI). The proposed training program in Lung Immunobiology is provided by a multidisciplinary, highly collaborative group of established investigators and highly qualified and dedicated mentors. We have included in the training program classical elements of basic and clinical-translational, research, adding on developing novel technologies. These research skills will enable our trainees to accelerate the advancements in lung research and close the gaps in knowledge that prevented for so many decades the development of phenotypic characterization, effective preventive intervention, and disease- modifying or even curative druts for most patients with lung disease. Being led by Program Director who is a renowned physician scientist and experienced mentor who himself is a minority, and having direct support from an experienced Minority Advisory Board, this application demonstrates our commitment to the development of a successful training program for under-represented and minority scientists. The Program Director will obtain continuous advise and feedback regarding the operation of the Training Grant from several internal and one external committee, composed of leaders in academic medicine If funded, this program will provide the only research training program of pulmonary physicians and scientists in the state of Indiana, which has one of the highest incidence of chronic lung diseases in the country.